| Net Cash Provided by (Used in) Financing Activities |
$95,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
35,311,829 |
shares |
-55% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,485 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$394,370 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$360,059 |
USD |
31% |
Q4 2024 |
FY 2024 |
| Depreciation |
$246 |
USD |
0.41% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$517,673 |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$98,894 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$360,059 |
USD |
31% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
17,895 |
shares |
426% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$10,125,703 |
USD |
830% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
17,895 |
shares |
459% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |